HNGE

HNGE Deferred Revenue

$416.47MQuarterly · USD

Period ending:

HNGE FY Deferred RevenueUSD
HNGE FY Deferred Revenue2023-12-31: $140.47M2024-12-31: $217.63M2025-12-31: $300.86M$300.86M$0.00
2023-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

HNGE deferred revenue history

Revenue received but not yet earned. The available annual fiscal periods series contains 3 observations from Dec 31, 2023 to Dec 31, 2025.

Hinge Health, Inc. Class A Common Stock Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
300,855,000
217,632,000
140,473,000

Compare deferred revenue

All HNGE financial metrics · HNGE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.